48th Annual Southeastern Wisconsin Cancer Conference: Advances in Melanoma

Milwaukee, WI US
April 9, 2016
This program will feature nationally recognized experts who will present information on prevention, risk assessment, early detection, and current and future treatment choices for melanoma patients.
ACCME Accreditation Statement:
This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint providership of the Medical College of Wisconsin and Wheaton Franciscan Healthcare. The Medical College of Wisconsin is accredited by the ACCME to provide continuing medical education for physicians.
AMA Credit Designation Statement:
The Medical College of Wisconsin designates this Live Activity for a maximum of 3.25 AMA PRA Category 1 Credit(s) ™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Hours of Participation for Allied Health Care Professionals
The Medical College of Wisconsin designates this activity for up to 3.25 hours of participation for continuing education for allied health professionals.
In accordance with the Americans with Disabilities Act, the Southeastern Wisconsin Cancer Conference seeks to make this conference accessible to all. If you have a disability, which might require special accommodations, please email your needs to: info@wicancerconference.org or call (262) 523-5547.

Target Audience

  • Physicians
  • Physician Assistants
  • Nurses
  • Nurse Practitioners
  • Pharmacists
  • Pharmacy Technicians
  • Allied Health Professionals

Learning Objectives

At the conclusion of this activity, I will be able to:

  • Describe a conceptual knowledge of the risk factors for melanoma, as well as screening and diagnostic strategies for melanoma.
  • Describe the basis for current surgical and non-surgical treatment approaches for melanoma.
  • Develop a practical knowledge of the effectiveness of current treatment strategies in terms of disease progression and disease-free survival/ cure.
  • Identify toxicities associated with the agents used to treat melanoma and develop strategies to manage those toxicities


Additional information


Mary Kissinger
Phone Number: 
+1 (414) 649-7250
Course summary
Available credit: 
  • 3.25 AMA PRA Category 1 Credit(s)™
    AMA PRA Category 1 Credit(s)™
  • 3.25 Hours of Participation
    Hours of Participation credit.
Course opens: 
Course expires: 
Event starts: 
04/09/2016 - 8:00am CDT
Event ends: 
04/09/2016 - 12:00pm CDT
Italian Community Center
631 E. Chicago Street
Milwaukee, WI 53202
United States
Italian Community Center
631 E. Chicago Street
Milwaukee, WI 53202-5916




SEWCC Program Planning Committee
Paul Ritch, MD - Chairman
Gerald Kallas, MD - Treasurer
Mary Kissinger, RHIA, CTR - Secretary
Deanna M. Birling, MSN, ANP-B AONP
Charles Bomzer, MD
Joseph Bovi, MD
Beth Brunner, ACS
Lynn Czaplewski, MS, RN
B.J. Gruling, RPh
Gerald Hanson, MD
Julie Jensen, RN, MSN, C-ANP
Thomas Jensen, MD
Kirk Ludwig, MD
Lisa Robinson, RHIA, CTR
Laura Raftery, MD
Carrie Ricconbono, MSN, RN, ACNS-BC, OCN
Paul Ritch, MD
Len Lichtenfeld, MD; American Cancer Society
Thomas Russell, MD; Medical College of Wisconsin
Merrick Ross, MD; MD Anderson
Michael Atkins, MD; Georgetown University
Amy Harker-Murray, MD- Medical College of Wisconsin
Lisa Holle, PharmD; University of Connecticut


All persons in control of content have NO relevant financial relationships to disclosure except the following:




In accordance with the ACCME®  Standards for Commercial Support Number 6, all in control of content disclosed any relevant financial relationships.  These relationships were reviewed via the MCW conflict of interest resolution process and resolved.

Available Credit

  • 3.25 AMA PRA Category 1 Credit(s)™
    AMA PRA Category 1 Credit(s)™
  • 3.25 Hours of Participation
    Hours of Participation credit.


Please login or register to take this course.